Fulton Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.2M Buy
14,349
+434
+3% +$443K 0.53% 45
2026
Q1
$12.8M Buy
13,915
+268
+2% +$272K 0.45% 44
2025
Q4
$14.7M Buy
13,647
+923
+7% +$883K 0.51% 41
2025
Q3
$9.71M Sell
12,724
-459
-3% -$342K 0.34% 54
2025
Q2
$10.3M Sell
13,183
-814
-6% -$633K 0.38% 49
2025
Q1
$11.6M Sell
13,997
-761
-5% -$633K 0.47% 43
2024
Q4
$11.4M Buy
14,758
+1,282
+10% +$1.06M 0.44% 42
2024
Q3
$11.9M Buy
13,476
+94
+0.7% +$84.5K 0.46% 41
2024
Q2
$12.1M Buy
13,382
+1,740
+15% +$1.39M 0.49% 40
2024
Q1
$9.06M Buy
11,642
+323
+3% +$230K 0.37% 47
2023
Q4
$6.6M Sell
11,319
-475
-4% -$277K 0.3% 60
2023
Q3
$6.33M Buy
11,794
+804
+7% +$414K 0.32% 60
2023
Q2
$5.15M Sell
10,990
-432
-4% -$181K 0.25% 71
2023
Q1
$3.92M Buy
11,422
+219
+2% +$73.9K 0.21% 86
2022
Q4
$4.1M Sell
11,203
-141
-1% -$50K 0.23% 83
2022
Q3
$3.67M Sell
11,344
-264
-2% -$83.6K 0.22% 80
2022
Q2
$3.76M Sell
11,608
-459
-4% -$138K 0.21% 82
2022
Q1
$3.46M Buy
12,067
+1,616
+15% +$416K 0.16% 104
2021
Q4
$2.89M Buy
10,451
+486
+5% +$123K 0.13% 119
2021
Q3
$2.3M Buy
9,965
+2,518
+34% +$621K 0.11% 135
2021
Q2
$1.71M Sell
7,447
-412
-5% -$82.8K 0.08% 168
2021
Q1
$1.47M Sell
7,859
-15,152
-66% -$2.96M 0.07% 186
2020
Q4
$3.88M Buy
23,011
+257
+1% +$38.4K 0.21% 88
2020
Q3
$3.37M Buy
22,754
+1,148
+5% +$178K 0.21% 93
2020
Q2
$3.55M Buy
21,606
+15,252
+240% +$2.34M 0.23% 83
2020
Q1
$882K Buy
6,354
+1,291
+25% +$177K 0.07% 186
2019
Q4
$665K Buy
5,063
+324
+7% +$37.6K 0.04% 240
2019
Q3
$530K Sell
4,739
-264
-5% -$29.4K 0.04% 251
2019
Q2
$554K Hold
5,003
0.04% 251
2019
Q1
$649K Buy
5,003
+466
+10% +$56.7K 0.05% 234
2018
Q4
$525K Sell
4,537
-50
-1% -$5.58K 0.04% 244
2018
Q3
$492K Sell
4,587
-143
-3% -$14.3K 0.03% 287
2018
Q2
$403K Hold
4,730
0.03% 321
2018
Q1
$366K Hold
4,730
0.03% 336
2017
Q4
$400K Sell
4,730
-301
-6% -$25.6K 0.03% 315
2017
Q3
$431K Hold
5,031
0.03% 297
2017
Q2
$414K Sell
5,031
-100
-2% -$8.16K 0.03% 283
2017
Q1
$432K Sell
5,131
-643
-11% -$51.5K 0.04% 260
2016
Q4
$425K Buy
5,774
+654
+13% +$48.7K 0.04% 263
2016
Q3
$411K Hold
5,120
0.04% 286
2016
Q2
$404K Sell
5,120
-20
-0.4% -$1.51K 0.04% 286
2016
Q1
$370K Sell
5,140
-378
-7% -$28.6K 0.04% 304
2015
Q4
$465K Buy
5,518
+1,016
+23% +$84.3K 0.05% 227
2015
Q3
$377K Hold
4,502
0.04% 251
2015
Q2
$376K Buy
4,502
+17
+0.4% +$1.29K 0.04% 258
2015
Q1
$326K Sell
4,485
-202
-4% -$14.4K 0.03% 271
2014
Q4
$324K Sell
4,687
-12,090
-72% -$816K 0.04% 263
2014
Q3
$1.09M Sell
16,777
-1,171
-7% -$74.1K 0.12% 129
2014
Q2
$1.12M Sell
17,948
-338
-2% -$20.2K 0.12% 132
2014
Q1
$1.08M Sell
18,286
-342
-2% -$19.1K 0.12% 134
2013
Q4
$950K Sell
18,628
-3,985
-18% -$200K 0.11% 142
2013
Q3
$1.14M Sell
22,613
-3,235
-13% -$169K 0.13% 123
2013
Q2
$1.27M Buy
+25,848
New +$1.41M 0.16% 114

Other funds holding LLY

Fulton Bank's LLY Position: Q2 2026 in Review

Fulton Bank increased its Eli Lilly (LLY) stake by 3.1% in Q2 2026, buying an estimated $443K and bringing the position to 14,349 shares worth $17.2M. The position accounts for 0.53% of the portfolio, ranked #45.

Fulton Bank first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 893 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fulton Bank held 14,349 shares of Eli Lilly worth $17.2M as of Q2 2026.
  • Fulton Bank bought 434 Eli Lilly shares in Q2 2026, an estimated $443K.
  • Eli Lilly made up 0.53% of Fulton Bank's portfolio in Q2 2026, its #45 holding.
  • Fulton Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 893 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.